Health-related Quality of Life of Men on Hormonal Therapy for Prostate Cancer

Lize Maree; Jacoba Jansen van Rensburg; Tikondwe Sichinga

doi:10.25159/2520-5293/10597

Authors

Lize Maree University of the Witwatersrand
Jacoba Jansen van Rensburg University of the Witwatersrand
Tikondwe Sichinga University of the Witwatersrand

DOI:

https://doi.org/10.25159/2520-5293/10597

Keywords:

South Africa, prostate cancer, hormonal treatment, health-related quality of life (HRQoL)

Abstract

Irrespective of the fact that prostate cancer is the most common cancer in South African men, little is known about the lives of men living with prostate cancer. This study aimed to describe the health-related quality of life (HRQoL) of men treated with hormonal therapy for prostate cancer. A cross sectional design, calculated sample size and convenience sampling method were used to recruit 113 men (n=113) treated at a tertiary hospital in the Gauteng Province. The EORTC QLQ-C30 and EORTC QLQ-PR25 questionnaires were used to collect the data. The data were analysed by means of descriptive statistics, and the Kruskall-Wallis H-test was used to compare the mean responses (p≤0.05). The ages of the sample (n=113) ranged from 52 to 96 years, with a mean of 68.8 years (SD±7.3). Overall health had the highest mean score (M=61; SD±19.1), compared to global health (M=60.5; SD±18.8), and HRQoL (M=60; SD±24.2). Social functioning was the domain that scored the lowest (M=72.6; SD±30.8), while hot flushes was the hormonal treatment-related symptom with the highest mean (M=46; SD±40.4). Hormonal therapy affected all the HRQoL domains of the men in our sample. However, the group 50 to 59 years of age and those in the first year of treatment had a better HRQoL compared to those 60 years and older and those in the second year of treatment. Nurses can enhance the HRQoL of these men through questioning, assessment and timely intervention.

Metrics

Metrics Loading ...

References

Aaronson, N. K., S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N. J. Duez, A. Filiberti, H. Flechtner, S. B. Fleishman, and J. C. de Hoes. 1993. “The European Organisation for Research and Treatment of Cancer QLQ-C30: A Quality of Life Instrument for Use in International Clinical Trials in Oncology.” Journal of the National Cancer Institute 85 (5): 365–376. https://doi.org/10.1093/jnci/85.5.365. DOI: https://doi.org/10.1093/jnci/85.5.365

Alibhai, S. M., H. Breunis, N. Timilshina, G. Naglie, I. Tannock, M. Krahn, P Warde, N. E. Fleshner, S. D. Canning, and G. Tomlinson. 2015. “Long-term Impact of Androgen-deprivation Therapy on Physical Function and Quality of Life.” Cancer 121 (14): 2350–2357. https://doi.org/10.1002/cncr.29355. DOI: https://doi.org/10.1002/cncr.29355

Cary, K. C., N. Singla, J. E. Cowan, P. R. Carroll, and M. R. Cooperberg. 2014. “Impact of Androgen Deprivation Therapy on Mental and Emotional Wellbeing in Men with Prostate Cancer: Analysis from the CaPSURE Registry.” Journal of Urology 191 (4): 964–970. https://doi.org/10.1016/j.juro.2013.10.098. DOI: https://doi.org/10.1016/j.juro.2013.10.098

Cassell, A., B. Yunusa, M. Jalloh, M. Ndoye, M. M. Mbodji, A. Diallo, S. Kouka, I. Labou, L. Niang, and S. M. Gueye. 2019. “Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline.” Journal of Oncology 2019. https://doi.org/10.1155/2019/1785428. DOI: https://doi.org/10.1155/2019/1785428

Cella, D. F. 1994. “Quality of Life: Concepts and Definition.” Journal of Pain and Symptom Management 9 (3): 186–192. https://doi.org/10.1016/0885-3924(94)90129-5. DOI: https://doi.org/10.1016/0885-3924(94)90129-5

Cheung, A. S., C. de Rooy, R. Hoermann, D. L. Joon, J. D. Zadac, and M. Grossmann. 2017. “Quality of Life Decrements in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy.” Clinical Endocrinology 86 (3): 388–394. https://doi.org/10.1111/cen.13249. DOI: https://doi.org/10.1111/cen.13249

Chung, S. D., L. T. Kao, H. C. Lin, S. Xirosagar, C. C. Huang, and H. C. Lee. 2017. “Patients Receiving Androgen Deprivation Therapy for Prostate Cancer Have an Increased Risk of Depressive Disorder.” PLOS ONE 12 (3). https://doi.org/10.1371/journal.pone.0173266. DOI: https://doi.org/10.1371/journal.pone.0173266

Donovan, K. A., B. D. Gonzalez, A. M. Nelson, M. N. Fishman, B. Zachariah, and P. B. Jacobsen. 2018. “Effect of Androgen Deprivation Therapy on Sexual Function and bother in Men with Prostate Cancer: A Controlled Comparison.” Psycho-Oncology 27 (1): 316–324. https://doi.org/10.1002/pon.4463. DOI: https://doi.org/10.1002/pon.4463

Eziefula, C. U., E. A. Grunfeld, and M. S. Hunter. 2013. “‘You Know I’ve Joined your Club … I’m the Hot Flush Boy’: A Qualitative Exploration of Hot Flushes and Night Sweats in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer.” Psycho-Oncology 22 (12): 2823–2830. https://doi.org/10.1002/pon.3355. DOI: https://doi.org/10.1002/pon.3355

Goker, A., T. Guvenal, E. Yanikkerem, A. Turhan and F. Koyuncu. 2011. “Quality of Life in Women with Gynaecologic Cancer in Turkey.” Asian Pacific Journal of Cancer Prevention 12 (11): 3121–3128.

Heale, R., and A. Twycross. 2015. “Validity and Reliability in Quantitative Studies.” Evidence-based Nursing 18 (3): 66–67. http://dx.doi.org/10.1136/eb-2015-102129. DOI: https://doi.org/10.1136/eb-2015-102129

Haffejee, M. 2016. “The Prostate Cancer Foundation of South Africa.” Accessed April 4, 2022. http://www.prostatecancerfoundation.co.za.

Hayes, V. M., and M. S. R. Bornman. 2018. “Prostate Cancer in Southern Africa: Does Africa Hold Untapped Potential to Add Value to the Current Understanding of a Common Disease?” Journal of Global Oncology 4: 1–7. https://doi.org/10.1200/jgo.2016.008862. DOI: https://doi.org/10.1200/JGO.2016.008862

Huang, I. S., A. T. L. Lin, H. H. H. Wu, H. J. Chung, J. Y. Kuo, and T. P. Lin. 2012. “Prostate Cancer Detection and Complication Rates with Transrectal Ultrasound-guided Prostate Biopsies among Different Operators.” Urological Science 23 (3): 78–81. http://dx.doi.org/10.1016/j.urols.2012.07.006. DOI: https://doi.org/10.1016/j.urols.2012.07.006

Jansen van Rensburg, J. J. M., J. E. Maree, and D. Casteleijn. 2017. “An Investigation into the Quality of Life of Cancer Patients in South Africa.” Asia Pacific Journal of Oncology Nursing 4 (4): 336–341. https://dx.doi.org/10.4103%2Fapjon.apjon_41_17. DOI: https://doi.org/10.4103/apjon.apjon_41_17

Jim, H. S. L., J. Y. Park, J. Permuth-Wey, M. A. Rincon, K. M. Phillips, B. J. Small, and P. B. Jacobson. 2012. “Genetic Predictors of Fatigue in Prostate Cancer Patients Treated with Androgen Deprivation Therapy: Preliminary Findings.” Brain, Behavior and Immunity 26 (7): 1030–1036. https://doi.org/10.1016/j.bbi.2012.03.001. DOI: https://doi.org/10.1016/j.bbi.2012.03.001

Kagawa-Singer, M., G. V. Padilla, and K. Ashing-Giwa. 2010. “Health-related Quality of Life and Culture.” Seminars in Oncology Nursing 26 (1): 59–67. https://doi.org/10.1016/j.soncn.2009.11.008. DOI: https://doi.org/10.1016/j.soncn.2009.11.008

Kim, S. H., D. H. Seong, and S. M. Yoon. 2017. “Predictors of Health-related Quality of Life in Korean Prostate Cancer Patients Receiving Androgen Deprivation Therapy.” European Journal of Oncology Nursing 30: 84–90. https://doi.org/10.1016/j.ejon.2017.08.009. DOI: https://doi.org/10.1016/j.ejon.2017.08.009

KwaZulu-Natal Province. 2019. “Prostate Cancer.” Accessed August 1, 2022. http://www.kznhealth.gov.za/prostate-cancer.htm.

Le Roux, H. A., R. J. Urry, B. Sartorius, and C. Aldous. 2015. “Prostate Cancer at a regional Hospital in South Africa: We Are only Seeing the Tip of the Iceberg.” South African Journal of Surgery 53 (4): 57–62.

Lin, X. J., I. M. Lin, and S. Y. Fan. 2013. “Methodological Issues in Measuring Health-related Quality of Life.” Tzu Chi Medical Journal 25 (1): 8–12. https://doi.org/10.1016/j.tcmj.2012.09.002. DOI: https://doi.org/10.1016/j.tcmj.2012.09.002

Mardani, A., S. P. Razi, R. Mazaheri, M. Dianatinasab, and M. Vaismoradi. 2020. “Health-related Quality of Life in Prostate Cancer in Survivors: Implications for Nursing Care.” International Journal of Caring Sciences 13 (2): 1322.

Maree, J. E., and J. J. M. Jansen van Rensburg. 2016. “Suitability of Quality-of-life Outcome Measures in Palliative Care in the South African Setting.” Palliative and Supportive Care: 1–11. https://doi.org/10.1017/S14789515000036.

Marusteri, M., and V. Bacarea. 2010. “Comparing Groups for Statistical Differences: How to Choose the right Statistical Test?” Biochemia Medica 20 (1): 15–32. https://doi.org/10.11613/BM.2010.004. DOI: https://doi.org/10.11613/BM.2010.004

Mohile, S. G., M. Lacy, M. Rodin, K. Bylow, W. Dale, M. R. Meager, and W. M. Stadler. 2010. “Cognitive Effects of Androgen Deprivation Therapy in an Older Cohort of Men with Prostate Cancer.” Critical Reviews in Oncology/Hematology 75 (2): 152–159. https://dx.doi.org/10.1016%2Fj.critrevonc.2010.06.009. DOI: https://doi.org/10.1016/j.critrevonc.2010.06.009

National Institute for Communicable Diseases. 2020. “Ekurhuleni Population-based Cancer Registry 2018 Annual Report.” Accessed April 4, 2022. https://www.nicd.ac.za/wp-content/uploads/2020/04/EPBCR-2018-report-Final-report.pdf.

Nishiyama, T., Y. Hashimoto, and K. Takahashi. 2004. “The Influence of Androgen Deprivation Therapy on Dihydrotestosterone Levels in the Prostatic Tissue of Patients with Prostate Cancer.” Clinical Cancer Research 10 (21): 7121–7126. https://doi.org/10.1158/1078-0432.ccr-04-0913. DOI: https://doi.org/10.1158/1078-0432.CCR-04-0913

O’Leary, E., F. Drummond, A. Gavin, H. Kinnear, and L. Sharp. 2015. “Psychometric Evaluation of the EORTC QLQ-PR25 Questionnaire in Assessing Health-related Quality of Life in Prostate Cancer Survivors: A Curate’s Egg.” Quality of life Research 24 (9): 2219–2230. https://doi.org/10.1007/s11136-015-0958-y. DOI: https://doi.org/10.1007/s11136-015-0958-y

Odeo, S., and A. Dego. 2020. “Factors Affecting Health-related Quality of Life among Prostate Cancer Patients: A Systematic Review.” Journal of Oncology Pharmacy Practice 26 (8):1997–2010. https://doi.org/10.1177/1078155220959414. DOI: https://doi.org/10.1177/1078155220959414

Patil, T., and B. Bernard. 2018. “Complications of Androgen Deprivation Therapy in Men with Prostate Cancer.” Oncology 32 (9): 470–474.

Pilkington, F. B., and G. J. Mitchell. 2004. “Quality of Life for Women Living with a Gynaecological Cancer.” Nursing Science Quarterly 17 (2): 147–155. https://doi.org/10.1177/0894318404263302. DOI: https://doi.org/10.1177/0894318404263302

Polit, D. F., and C. T. Beck. 2018. Essentials of Nursing Research: Appraising Evidence for Nursing Practice, 9th edition. Philadelphia: Lippincott Williams.

Raosoft. 2004. “Sample Size Calculator.” Accessed January 4, 2022. http://www.raosoft.com/samplesize.html.

SANews. 2017. “Charlotte Maxeke Hospital Leading in Cancer Treatment.” Accessed March 20, 2017. https://www.sanews.gov.za/south-africa/charlotte-maxeke-hospital-leading-cancer-treatment.

Selli, C., A. Bjartell, J. Burgos, M. Somerville, M. Palacios, L. Benjamin, L. Black, and R. Castro. 2014. “Burden of Illness in Prostate Cancer Patients with a low-to-moderate Risk of Progression: A one-year, pan-European Observational Study.” Prostate Cancer 2014:472949. https://doi.org/10.1155/2014/472949. DOI: https://doi.org/10.1155/2014/472949

Siston, A. K., S. J. Knight, and N. P. Slimack. 2003. “Quality of Life after a Diagnosis of Prostate Cancer among Men of lower socioeconomic status: Results from the Veterans’ Affairs Cancer of the Prostate Outcomes Study.” Urology 61 (1): 172–178. https://doi.org/10.1016/s0090-4295(02)02141-6. DOI: https://doi.org/10.1016/S0090-4295(02)02141-6

Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 71 (3): 209–249. https://doi.org/10.3322/caac.21660. DOI: https://doi.org/10.3322/caac.21660

Ueno, S., Y. Kitagawa, M. Onozawa, M. Namiki, S. Hinotsu, H. Akaza, and A. Mizokami. 2018. “Background Factors and short-term health-related Quality of Life in Patients who initially Underwent Radical Prostatectomy or Androgen Deprivation Therapy for localized Prostate Cancer in a Japanese Prospective Observational Study.” Prostate International 6 (1): 7–11. https://doi.org/10.1016/j.prnil.2017.05.004. DOI: https://doi.org/10.1016/j.prnil.2017.05.004

Van Andel, G., and K. H. Kurth. 2003. “The Impact of Androgen Deprivation Therapy on health-related Quality of Life in Asymptomatic Men with Lymph Node Positive Prostate Cancer.” European Urology 44 (2): 209–214. https://doi.org/10.1016/s0302-2838(03)00208-2. DOI: https://doi.org/10.1016/S0302-2838(03)00208-2